Global Shingles Vaccine Market 2020-2024

Global Shingles Vaccine Market 2020-2024.

The publisher has been monitoring the global shingles vaccine market 2020-2024 and it is poised to grow by USD 1.08 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period. The report on the global shingles vaccine market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by approval of shingles vaccines and favorable reimbursement policies. In addition, high incidence and prevalence of shingles is anticipated to boost the growth of the global shingles vaccine market 2020-2024 as well.

Market Segmentation

The publisher's global shingles vaccine market 2020-2024 is segmented as below:

Type:

Recombinant Vaccines
Live-attenuated Vaccines

Geographic Segmentation:

North America
Europe
Asia
ROW

Key Trends for global shingles vaccine market 2020-2024 growth

This study identifies high incidence and prevalence of shingles as the prime reasons driving the global shingles vaccine market 2020-2024 growth during the next few years.

Prominent vendors in global shingles vaccine Market 2020-2024.

The publisher provides a detailed analysis of around 25 vendors operating in the global shingles vaccine market 2020-2024, including some of the vendors such as CanSino Biologics Inc., Curevo Inc., GeneOne Life Science Inc., GlaxoSmithKline Plc, Merck & Co. Inc., SK Bioscience and Vaccitech Ltd. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Executive Summary

Market Overview

Market Landscape

Market ecosystem
Value chain analysis

Market Sizing

Market definition
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Type

Market segments
Comparison by Type placement
Recombinant vaccines - Market size and forecast 2019-2024
Live-attenuated vaccines - Market size and forecast 2019-2024
Market opportunity by Type

Customer landscape

Overview

Geographic Landscape

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography

Drivers, Challenges, and Trends

Market drivers
Volume driver - Demand led growth
Volume driver - Supply led growth
Volume driver - External factors
Volume driver - Demand shift in adjacent markets
Price driver - Inflation
Price driver - Shift from lower to higher-priced units
Market challenges
Market trends

Vendor Landscape

Overview
Landscape disruption

Vendor Analysis

Vendors covered
Market positioning of vendors
CanSino Biologics, Inc.
Curevo Inc.
GeneOne Life Science Inc.
GlaxoSmithKline Plc
Merck & Co., Inc.
SK Bioscience
Vaccitech Ltd.

Appendix

Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

List of Exhibits

1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Key Finding 8
8. Market in focus
9. Parent market
10. Market characteristics
11. Product / Service portfolio of key vendors included in the market definition
12. Market segments
13. Global - Market size and forecast 2019 - 2024 ($ million)
14. Global market: Year-over-year growth 2019 - 2024 (%)
15. Five forces analysis 2019 & 2024
16. Bargaining power of buyers
17. Bargaining power of suppliers
18. Threat of new entrants
19. Threat of substitutes
20. Threat of rivalry
21. Market condition - Five forces 2019
22. Type placement - Market share 2019-2024 (%)
23. Comparison by Type placement
24. Recombinant vaccines - Market size and forecast 2019-2024 ($ million)
25. Recombinant vaccines - Year-over-year growth 2019-2024 (%)
26. Live-attenuated vaccines - Market size and forecast 2019-2024 ($ million)
27. Live-attenuated vaccines - Year-over-year growth 2019-2024 (%)
28. Market opportunity by Type
29. Customer landscape
30. Market share by geography 2019-2024 (%)
31. Geographic comparison
32. North America - Market size and forecast 2019-2024 ($ million)
33. North America - Year-over-year growth 2019-2024 (%)
34. Europe - Market size and forecast 2019-2024 ($ million)
35. Europe - Year-over-year growth 2019-2024 (%)
36. Asia - Market size and forecast 2019-2024 ($ million)
37. Asia - Year-over-year growth 2019-2024 (%)
38. ROW - Market size and forecast 2019-2024 ($ million)
39. ROW - Year-over-year growth 2019-2024 (%)
40. Key leading countries
41. Market opportunity by geography ($ million)
42. Impact of drivers and challenges
43. Vendor landscape
44. Landscape disruption
45. Industry risks
46. Vendors covered
47. Market positioning of vendors
48. CanSino Biologics Inc. - Overview
49. CanSino Biologics Inc. - Product and service
50. CanSino Biologics Inc. - Key offerings
51. CanSino Biologics Inc. - Key customers
52. CanSino Biologics Inc. - Segment focus
53. Curevo Inc. - Overview
54. Curevo Inc. - Product and service
55. Curevo Inc. - Key offerings
56. Curevo Inc. - Key customers
57. Curevo Inc. - Segment focus
58. GeneOne Life Science Inc. - Overview
59. GeneOne Life Science Inc. - Product and service
60. GeneOne Life Science Inc. - Key offerings
61. GeneOne Life Science Inc. - Key customers
62. GeneOne Life Science Inc. - Segment focus
63. GlaxoSmithKline Plc - Overview
64. GlaxoSmithKline Plc - Business segments
65. GlaxoSmithKline Plc - Key offerings
66. GlaxoSmithKline Plc - Key customers
67. GlaxoSmithKline Plc - Segment focus
68. Merck & Co. Inc. - Overview
69. Merck & Co. Inc. - Business segments
70. Merck & Co. Inc. - Key offerings
71. Merck & Co. Inc. - Key customers
72. Merck & Co. Inc. - Segment focus
73. SK Bioscience - Overview
74. SK Bioscience - Product and service
75. SK Bioscience - Key offerings
76. SK Bioscience - Key customers
77. SK Bioscience - Segment focus
78. Vaccitech Ltd. - Overview
79. Vaccitech Ltd. - Product and service
80. Vaccitech Ltd. - Key offerings
81. Vaccitech Ltd. - Key customers
82. Vaccitech Ltd. - Segment focus
83. Currency conversion rates for US$
84. Research Methodology
85. Validation techniques employed for market sizing
86. Information sources
87. List of abbreviations

Executive Summary

The publisher Announces the Publication of its Research Report-Global Shingles Vaccine Market 2020-2024.

The publisher recognizes the following companies as the key players in the global shingles vaccine market: CanSino Biologics Inc., Curevo Inc., GeneOne Life Science Inc., GlaxoSmithKline Plc, Merck & Co. Inc., SK Bioscience and Vaccitech Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the high incidence and prevalence of shingles."

According to the report, one of the major drivers for this market is the approval of shingles vaccines and favorable reimbursement policies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.